PHARMACOKINETIC INTERACTION OF ZONISAMIDE IN RATS - EFFECT OF OTHER ANTIEPILEPTICS ON ZONISAMIDE

被引:18
|
作者
KIMURA, M
TANAKA, N
KIMURA, Y
MIYAKE, K
KITAURA, T
FUKUCHI, H
机构
[1] Department of Pharmaceutical Services, Hiroshima University Hospital, Minami-ku, Hiroshima 734, Kasumi
来源
JOURNAL OF PHARMACOBIO-DYNAMICS | 1992年 / 15卷 / 11期
关键词
ZONISAMIDE; PHARMACOKINETIC INTERACTION; ANTIEPILEPTIC DRUG; PROTEIN BINDING; ERYTHROCYTE DISTRIBUTION; METABOLISM;
D O I
10.1248/bpb1978.15.631
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics Of zonisamide (ZNS) and the effects of phenobarbital (PB), valproic acid (VPA), carbamazepine (CBZ) and phenytoin (PHT) on ZNS kinetics were investigated in rats. The effects of other antiepileptics on the serum protein binding, erythrocyte distribution and metabolism of ZNS were also studied in vitro to elucidate the mechanism of pharmacokinetic interaction of ZNS. ZNS showed a linear disposition kinetics after oral administration of ZNS within the dose examined. Moreover, the pharmacokinetic behaviors of ZNS were not altered after multiple dosing. The decreased t1/2 value of ZNS by PB or CBZ pretreatment and the increased Vd/F value of ZNS by VPA pretreatment were observed, although it showed no marked effect of PHT on ZNS kinetics. The enhanced metabolism of ZNS was observed by PB or CBZ pretreatmtent from an in vitro metabolism study. The serum protein binding and erythrocyte distribution of ZNS showed no significant change in the presence of other antiepileptics in vitro. These results indicate that the decreased t1/2 value of ZNS is attributable to the enzyme inducing effect of PB or CBZ, and that neither protein binding nor erythrocyte distribution of ZNS could be the reason for the increased Vd/F value of ZNS by VPA coadministration.
引用
收藏
页码:631 / 639
页数:9
相关论文
共 50 条
  • [21] Lack of Pharmacokinetic Interactions Between Steady-State Zonisamide and Valproic Acid in Patients with Epilepsy
    Isabelle Ragueneau-Majlessi
    Rene H. Levy
    Martin Brodie
    David Smith
    Jaymin Shah
    John S. Grundy
    Clinical Pharmacokinetics, 2005, 44 : 517 - 523
  • [22] Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy
    Levy, RH
    Ragueneau-Majlessi, I
    Brodie, MJ
    Smith, DE
    Shah, D
    Pan, WJ
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 193 - 198
  • [23] Zonisamide suppresses the tonic phase but not the clonic phase of generalized seizures in developing rats
    Mares, Pavel
    EPILEPSY RESEARCH, 2010, 92 (2-3) : 244 - 248
  • [24] ZONISAMIDE REDUCES HYPOXIC-ISCHEMIC BRAIN-DAMAGE IN NEONATAL RATS IRRESPECTIVE OF ITS ANTICONVULSIVE EFFECT
    HAYAKAWA, T
    HIGUCHI, Y
    NIGAMI, H
    HATTORI, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (1-2) : 131 - 136
  • [25] Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease
    Ueda, Yuto
    Tokashiki, Shoko
    Kanemaru, Ai
    Kojima, Toshio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 428 (03) : 401 - 404
  • [26] The effect of oral zonisamide treatment on serum phenobarbital concentrations in epileptic dogs
    Mahon, Elizabeth
    Marsh, Oliver
    Uriarte, Ane
    Stabile, Fabio
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [27] FREE-RADICAL SCAVENGING ACTIVITY OF ZONISAMIDE AND ITS INHIBITORY EFFECT ON LIPID PEROXIDE FORMATION IN IRON-INDUCED EPILEPTOGENIC FOCI OF RATS
    KOMATSU, M
    OKAMURA, Y
    HIRAMATSU, M
    NEUROSCIENCES-JAPAN, 1995, 21 (01): : 23 - 29
  • [28] Rapid and Sensitive High Performance Liquid Chromatographic Determination of Zonisamide in Human Serum Application to a Pharmacokinetic Study
    Majnooni, M. B.
    Mohammadi, B.
    Jalili, R.
    Bahrami, G. H.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 74 (04) : 360 - 364
  • [29] The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs
    Shinoda, M
    Akita, M
    Hasegawa, M
    Hasegawa, T
    Nabeshima, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (08) : 1090 - 1092
  • [30] Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol
    Morita, S
    Miwa, H
    Kondo, T
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (02) : 101 - 103